02/06/2019 Physiogenex to present at the Keystone Obesity and Adipose Tissue Biology in Banff, Alberta, Canada
Physiogenex will present at the Keystone Symposia Obesity and Adipose Tissue Biology, on February 11, 2019 during the Poster Session 1 (19:30 – 22:00).
Poster (#1021): “Green coffee better improves body weight loss and metabolic disorders than green tea in diet-induced obese mice”.
Dr. François Briand, Director of Research and Business Development will be happy to discuss with you about your preclinical obesity project, explore it and share with you his expertise. Please contact us to set-up an appointment.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.